热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE anti-mouse/human CD45R/B220 Antibody
产品名称：
PE anti-mouse/human CD45R/B220 Antibody
产品类别：
抗体
产品编号：
103207
产品应用：
103207
[价格]
规格 价格 库存
50µg ￥ 616 1

产品详情

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  15. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  2. Ho J, et al. 2016. PLoS Biol. 14:e2000117. PubMed
  3. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  4. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  5. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  6. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  7. Li Y, et al. 2016. Nat Commun. 7:10836. PubMed
  8. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  9. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  10. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  11. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  12. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  13. Wong J, et al. 2015. Elife. 3: 07839. PubMed
  14. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  15. Franks SE, et al. 2019. J Immunol. 202:3381. PubMed
  16. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  17. Nguyen T, et al. 2014. J Exp Med. 211:1011. PubMed
  18. Cravens P, et al. 2016. PLoS One. 11:e0165248. PubMed
  19. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  20. Zape J, et al. 2017. Cell Cycle. 10.1080/15384101.2017.1361569. PubMed
  21. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  22. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  23. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  24. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  25. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  26. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  27. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  28. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  29. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  30. Li J, et al. 2019. JCI Insight. 5. PubMed
  31. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  32. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  33. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  34. Tsukasaki M, et al. 2020. Cell Reports. 32(10):108124. PubMed
  35. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  36. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  37. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  38. Onodera T, et al. 2016. J Immunol. 196: 4172 - 4184. PubMed
  39. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  40. Lasso P, et al. 2020. Front Immunol. 584959:11. PubMed
  41. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  42. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  43. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  44. Nguyen T, et al. 2016. Sci Rep. 6:36906. PubMed
  45. Fu T, et al. 2011. Mol Immunol. 48:751. PubMed
  46. Khatib–Massalha E, et al. 2020. Nat Commun. 2.921527778. PubMed
  47. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  48. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  49. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  50. White C, et al. 2015. J Immunol. 194:697. PubMed
  51. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  52. Cook KD, et al. 2015. Immunity. 43:703-714. PubMed
  53. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  54. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  55. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  56. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  57. Cho K, et al. 2021. iScience. 24:103117. PubMed
  58. Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed
  59. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  60. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  61. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  62. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
  63. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  64. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  65. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  66. Wu T, et al. 2014. J Leukoc Biol. 95:215. PubMed
  67. Zhu X et al. 2019. Cell reports. 27(4):1205-1220 . PubMed
  68. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  69. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  70. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  71. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  72. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  73. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  74. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  75. Lu W, et al. 2016. PLoS One. 11: 0149543. PubMed
  76. Faingold O, et al. 2013. J Biol Chem. 288:32852. PubMed
  77. Wang D, et al. 2005. Int Immunol. 1.527083333. PubMed
  78. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  79. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  80. Saveljeva S, et al. 2022. Cell Metab. 34:106. PubMed
  81. Liang Q, et al. 2020. Front Microbiol. 11:571847. PubMed
  82. Ha TC, et al. 2020. Hum Gene Ther. 32:458. PubMed
  83. Martin R, et al. 2014. PLoS One. 9:110609. PubMed
  84. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  85. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  86. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  87. Zhu L, et al. 2022. Cells. 11:. PubMed
  88. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  89. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  90. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  91. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  92. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  93. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  94. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  95. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  96. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  97. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  98. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  99. Lim J, et al. 2017. Cell. 169:523. PubMed
  100. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  101. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  102. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  103. Chang C, et al. 2007. J Immunol . 178:6984. PubMed
  104. Platteel ACM, et al. 2018. Front Immunol. 1.544444444. PubMed
  105. Oh B, et al. 2017. Plast Reconstr Surg Glob Open. 5:e1595. PubMed
  106. Katsuyama T, et al. 2019. J Clin Invest. 129:5411. PubMed
  107. Feng M, et al. 2012. Int Immunopharmacol. 13:135. PubMed
  108. Adachi Y, et al. 2015. J Exp Med. 212: 1709-1723. PubMed
  109. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  110. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  111. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  112. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  113. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  114. Uotila LM, et al. 2017. J Immunol. 199:3644. PubMed
  115. Kanaya T, et al. 2008. Am J Physiol Gastrointest Liver Physiol. 295:273. PubMed
  116. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  117. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  118. Gawish R, et al. 2022. Elife. 11:. PubMed
  119. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  120. Park CJ, et al. 2020. Cell Reports. 31(2):107496.. PubMed
  121. Zheng QY, et al. 2019. Front Immunol. 10:1866. PubMed
  122. Cabal-Hierro L, et al. 2020. Nat Commun. 11:1406. PubMed
RRID
AB_312992 (BioLegend Cat. No. 103207) AB_312993 (BioLegend Cat. No. 103208)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线